ATE78687T1 - Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen. - Google Patents

Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.

Info

Publication number: ATE78687T1
Authority: AT; Austria
Prior art keywords: noroxymorphone; nausea; vomiting; treatment; quaternary derivatives
Prior art date: 1987-09-10

Application number

AT87307999T

Other languages

English (en)

Inventor

Leon I Goldberg

Original Assignee

Univ Chicago

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1987-09-10

Filing date

1987-09-10

Publication date

1992-08-15

1987-09-10 Application filed by Univ Chicago filed Critical Univ Chicago

1992-08-15 Application granted granted Critical

1992-08-15 Publication of ATE78687T1 publication Critical patent/ATE78687T1/de

Links

HLMSIZPQBSYUNL-IPOQPSJVSA-N Noroxymorphone Chemical group O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(O)C2=C5[C@@]13CCN4 HLMSIZPQBSYUNL-IPOQPSJVSA-N 0.000 title abstract 2
206010047700 Vomiting Diseases 0.000 title abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
JVLBPIPGETUEET-WIXLDOGYSA-O (3r,4r,4as,7ar,12bs)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1h-4,12-methanobenzofuro[3,2-e]isoquinoline-3-ium-7-one Chemical compound C([N@+]1(C)[C@@H]2CC=3C4=C(C(=CC=3)O)O[C@@H]3[C@]4([C@@]2(O)CCC3=O)CC1)C1CC1 JVLBPIPGETUEET-WIXLDOGYSA-O 0.000 abstract 1
206010028813 Nausea Diseases 0.000 abstract 1
230000000202 analgesic effect Effects 0.000 abstract 1
229940035676 analgesics Drugs 0.000 abstract 1
239000000730 antalgic agent Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002452 interceptive effect Effects 0.000 abstract 1
229960002921 methylnaltrexone Drugs 0.000 abstract 1
239000004084 narcotic analgesic agent Substances 0.000 abstract 1
230000003533 narcotic effect Effects 0.000 abstract 1
230000008693 nausea Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine

Landscapes

Health & Medical Sciences (AREA)
Emergency Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT87307999T 1987-09-10 1987-09-10 Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen. ATE78687T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP87307999A EP0306575B1 (de)	1987-09-10	1987-09-10	Quaternäre Derivate von Noroxymorphon zur Behandlung von Übelkeit und Erbrechen

Publications (1)

Publication Number	Publication Date
ATE78687T1 true ATE78687T1 (de)	1992-08-15

Family

ID=8198027

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT87307999T ATE78687T1 (de)	1987-09-10	1987-09-10	Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.

Country Status (5)

Country	Link
EP (1)	EP0306575B1 (de)
AT (1)	ATE78687T1 (de)
DE (1)	DE3780819T2 (de)
ES (1)	ES2051742T3 (de)
GR (1)	GR3005834T3 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274591B1 (en) *	1997-11-03	2001-08-14	Joseph F. Foss	Use of methylnaltrexone and related compounds
PT1543010E (pt) *	2002-09-25	2007-07-26	Euro Celtique Sa	Hidromorfonas n-substituídas e a sua utilização
CA2811272C (en)	2003-04-08	2016-12-20	Progenics Pharmaceuticals, Inc.	Pharmaceutical formulations containing methylnaltrexone
US8524731B2 (en)	2005-03-07	2013-09-03	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
ES2714198T3 (es)	2005-03-07	2019-05-27	Univ Chicago	Uso de antagonistas opioideos para atenuar la proliferación y la migración de células endoteliales
US8518962B2 (en)	2005-03-07	2013-08-27	The University Of Chicago	Use of opioid antagonists
US9662325B2 (en)	2005-03-07	2017-05-30	The University Of Chicago	Use of opioid antagonists to attenuate endothelial cell proliferation and migration
AR057035A1 (es)	2005-05-25	2007-11-14	Progenics Pharm Inc	SíNTESIS DE (R)-N-METILNALTREXONA, COMPOSICIONES FARMACÉUTICAS Y USOS
AR057325A1 (es)	2005-05-25	2007-11-28	Progenics Pharm Inc	Sintesis de (s)-n-metilnaltrexona, composiciones farmaceuticas y usos
TWI489984B (zh)	2006-08-04	2015-07-01	Wyeth Corp	用於非經腸道傳輸化合物之配方及其用途
JP2010522756A (ja)	2007-03-29	2010-07-08	プロジェニックスファーマシューティカルズ，インコーポレーテッド	結晶形およびその使用
PL2137191T3 (pl)	2007-03-29	2016-12-30		Antagoniści obwodowego receptora opioidowego i ich zastosowania
EP2565195B1 (de)	2007-03-29	2015-05-06	Wyeth LLC	Peripherer Opioid-Rezeptor sowie Antagonisten und Verwendungen davon
AU2008349873B2 (en)	2008-02-06	2014-02-13	Progenics Pharmaceuticals, Inc.	Preparation and use of (R),(R)-2,2'-bis-methylnaltrexone
CA2719134C (en)	2008-03-21	2015-06-30	The University Of Chicago	Treatment with opioid antagonists and mtor inhibitors
CA2676881C (en)	2008-09-30	2017-04-25	Wyeth	Peripheral opioid receptor antagonists and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1202148A (en) *	1968-03-06	1970-08-12	Sankyo Co	Pharmaceutical compositions
US4176186A (en) *	1978-07-28	1979-11-27	Boehringer Ingelheim Gmbh	Quaternary derivatives of noroxymorphone which relieve intestinal immobility
US4466968A (en) *	1980-11-24	1984-08-21	Dermall, Ltd.	Method for prophylaxis or treatment of emesis and nausea
EP0103636B1 (de) *	1982-03-16	1990-09-12	Rockefeller University	Verwendung von opium antagonisten zur herstellung von arzneimitteln zur behebung gastro-intestinaler störungen

1987
- 1987-09-10 EP EP87307999A patent/EP0306575B1/de not_active Expired
- 1987-09-10 AT AT87307999T patent/ATE78687T1/de not_active IP Right Cessation
- 1987-09-10 DE DE8787307999T patent/DE3780819T2/de not_active Expired - Lifetime
- 1987-09-10 ES ES87307999T patent/ES2051742T3/es not_active Expired - Lifetime
1992
- 1992-09-30 GR GR920402167T patent/GR3005834T3/el unknown

Also Published As

Publication number	Publication date
EP0306575B1 (de)	1992-07-29
DE3780819T2 (de)	1993-01-14
DE3780819D1 (de)	1992-09-03
ES2051742T3 (es)	1994-07-01
EP0306575A1 (de)	1989-03-15
GR3005834T3 (de)	1993-06-07

Similar Documents

Publication	Publication Date	Title
ATE78687T1 (de)	1992-08-15	Quaternaere derivate von noroxymorphon zur behandlung von uebelkeit und erbrechen.
IL92269A0 (en)	1990-07-26	Pharmaceutical composition for treatment of autoimmune diseases
DK644488D0 (da)	1988-11-18	Farmaceutisk praeparat indeholdende ismn med kontrolleret absorbtion
NO996310D0 (no)	1999-12-17	Sammensetninger og fremgangsmåter for å redusere respirasjonsdepresjon og ledsagende bivirkninger av mu-opioide forbindelser
NL970006I2 (nl)	1997-10-01	Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson.
MY130145A (en)	2007-06-29	Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
WO2001013909A3 (en)	2001-05-25	Compositions and methods for treating opiate intolerance
DK0724885T3 (da)	2002-05-21	Pernasal sammensætning og pernasalt præparat indeholdende dette
NO894295D0 (no)	1989-10-27	Fremgangsmaate for behandling av interstitiell cystitt.
ES2032905T3 (es)	1993-03-01	Sistema terapeutico transcutaneo.
ATE284206T1 (de)	2004-12-15	Transdermal verabreichtes dextromethorphan als hustenmittel
ES2099344T3 (es)	1997-05-16	Preparado de combinacion a base de flupirtina y morfina para el tratamiento de dolores y para evitar la adiccion a morfina.
Weingart et al.	1985	Analgesia with oral narcotics and added ibuprofen in cancer patients
JPS6483020A (en)	1989-03-28	Medicinal composition for preventing or treating aids
GR3025518T3 (en)	1998-02-27	Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
GR3018335T3 (en)	1996-03-31	Use of a pure narcotic antagonist, e.g. nalmefene, naltrexone, naloxone or diprenorphine, in the treatment of mast cell disease.
NO883250D0 (no)	1988-07-21	Opoid analgesisk lipsomalt frigjoeringssystem for terapeutiske midler.
DE68910010D1 (de)	1993-11-25	Verwendung von Dapiprazol zur Herstellung eines Arzneimittels zur Verhinderung des Toleranzentwicklung bei der analgetischen Behandlung mit Morphin.
RU94042516A (ru)	1996-11-10	Способ купирования опийного абстинентного синдрома
UA30654A (uk)	2000-12-15	Спосіб лікування посттравматичних дисфункцій висково- нижньощелепового суглоба
SE8304818L (sv)	1985-03-09	Medicin med magsarslekande, spasmolytisk och lokalanesteserande verkan
KR920007631A (ko)	1992-05-27	척수손상 치료용 세로토닌 길항제

Legal Events

Date	Code	Title	Description
1993-03-15	UEP	Publication of translation of european patent specification
2007-12-15	EELA	Cancelled due to lapse of time